Physician profile
Argenis J Herrera Garcia
NPI 1467725622
$41,028.91
in general payments reported to CMS, 2019-2025
10 companies · $3,726 in 2025
The $3,726 reported for 2025 was more than what 78% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $384 · 2020: $1,444 · 2021: $118 · 2022: $130 · 2023: $35K · 2024: $38.07 · 2025: $3,726.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $35K · Travel and Lodging: $3,513 · Food and Beverage: $440.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $35,000.00 |
| Travel and Lodging | $3,512.94 |
| Food and Beverage | $439.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $38,756.74 | 2020-2025 | Davinci Xi, Da Vinci Surgical System, Da Vinci Sp |
| Ethicon INC. | $874.15 | 2022-2023 | Monarch Platform |
| Boston Scientific Corporation | $826.99 | 2019-2020 | |
| Becton, Dickinson and Company | $162.03 | 2019 | |
| Olympus America INC. | $118.01 | 2021 | |
| Atricure, INC. | $94.09 | 2023 | |
| Caris Mpi, INC. | $88.75 | 2025 | Mi Cancer Seek |
| Kls-Martin L.P. | $47.11 | 2022-2024 | |
| Endogastric Solutions, INC | $40.08 | 2023 | Esophyx |
| Solventum Corporation | $20.96 | 2024 | V.A.C.Ulta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Argenis Herrera Garcia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.